IRIS
PRETE, MARCELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.032
EU - Europa 3.522
AS - Asia 3.364
SA - Sud America 853
Continente sconosciuto - Info sul continente non disponibili 444
AF - Africa 159
OC - Oceania 6
Totale 15.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.895
IT - Italia 1.556
SG - Singapore 1.351
CN - Cina 725
BR - Brasile 652
HK - Hong Kong 415
SE - Svezia 410
RU - Federazione Russa 329
VN - Vietnam 265
DE - Germania 263
FR - Francia 242
FI - Finlandia 176
GB - Regno Unito 158
UA - Ucraina 148
IN - India 113
BD - Bangladesh 112
AR - Argentina 75
CA - Canada 50
ID - Indonesia 50
IQ - Iraq 44
MX - Messico 44
TR - Turchia 43
JP - Giappone 42
NL - Olanda 42
CI - Costa d'Avorio 40
ZA - Sudafrica 36
EC - Ecuador 33
ES - Italia 32
PL - Polonia 31
PH - Filippine 30
PK - Pakistan 29
CO - Colombia 25
VE - Venezuela 25
BE - Belgio 24
AT - Austria 21
SA - Arabia Saudita 21
UZ - Uzbekistan 20
IE - Irlanda 19
MA - Marocco 18
CL - Cile 17
CZ - Repubblica Ceca 15
MY - Malesia 15
TN - Tunisia 14
CH - Svizzera 12
TW - Taiwan 12
JO - Giordania 11
LT - Lituania 10
PY - Paraguay 10
KE - Kenya 9
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
DZ - Algeria 7
JM - Giamaica 7
PS - Palestinian Territory 7
SY - Repubblica araba siriana 7
TT - Trinidad e Tobago 7
EG - Egitto 6
KR - Corea 6
PE - Perù 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
EU - Europa 5
SN - Senegal 5
AU - Australia 4
CR - Costa Rica 4
HR - Croazia 4
IL - Israele 4
KZ - Kazakistan 4
RO - Romania 4
SV - El Salvador 4
UY - Uruguay 4
AL - Albania 3
AO - Angola 3
BB - Barbados 3
BO - Bolivia 3
IR - Iran 3
KG - Kirghizistan 3
MD - Moldavia 3
NI - Nicaragua 3
NP - Nepal 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BG - Bulgaria 2
BZ - Belize 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
MT - Malta 2
NG - Nigeria 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
SR - Suriname 2
AM - Armenia 1
Totale 14.915
Salva come PNG Salva come JPEG
Città #
Singapore 740
Ashburn 707
Chandler 595
San Jose 516
Fairfield 444
Hong Kong 411
Woodbridge 373
Milan 353
Jacksonville 345
Nyköping 331
Houston 294
Beijing 263
Seattle 225
Bari 221
Ann Arbor 215
Cambridge 204
Council Bluffs 194
Wilmington 192
New York 154
Rome 143
Lauterbourg 109
Lawrence 104
Roxbury 104
Dallas 97
Los Angeles 97
Nanjing 91
Helsinki 86
Ho Chi Minh City 85
Des Moines 71
Boardman 70
Santa Clara 69
Munich 64
São Paulo 61
Hanoi 59
Columbus 52
Brooklyn 51
Princeton 50
Buffalo 46
Inglewood 45
Abidjan 40
Chicago 39
Moscow 38
Orem 34
Falkenstein 33
Marseille 32
Tokyo 29
Jakarta 28
London 28
Pune 27
Rio de Janeiro 26
Shenyang 26
Palermo 25
Frankfurt am Main 24
Paris 24
Phoenix 24
Warsaw 23
Brussels 22
Johannesburg 22
San Diego 22
Atlanta 21
Hebei 21
Nanchang 21
Florence 20
Tashkent 20
Bologna 19
Dearborn 19
Nuremberg 19
Turin 19
Denver 18
Stockholm 18
Baghdad 17
Naples 17
Poplar 17
Belo Horizonte 16
Chennai 16
Dong Ket 16
Tianjin 16
Toronto 16
Guangzhou 15
Mexico City 15
Montreal 15
Figino 14
Noicattaro 14
Vienna 14
Brasília 13
Quito 13
Washington 13
Dhaka 12
Dublin 12
Jiaxing 12
Manchester 12
Turku 12
Amsterdam 11
Ankara 11
Brno 11
Guayaquil 11
Porto Alegre 11
Redwood City 11
The Dalles 11
Changsha 10
Totale 9.516
Salva come PNG Salva come JPEG
Nome #
L'immunoparesi nel mieloma multiplo 738
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 226
Autoimmune uveitis: clinical, pathogenetic, and therapeutic features 205
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 199
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 193
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 188
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 181
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 172
Autoantibodies to intracellular antigens: generation and pathogenetic role 172
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 171
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 170
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 167
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 167
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 166
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 159
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 159
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 158
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 157
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 155
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis 155
Lupus vasculitis: An overview 153
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 151
Effectiveness and safety of belimumab in patients with active systemic lupus erythematosus: results from a large, nationwide, multicentric study. 151
Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins a case report 149
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 148
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 147
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 145
Rheumatic disorders as paraneoplastic syndromes 143
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 143
Vasculitides: Proposal for an integrated nomenclature 140
CD20: A target antigen for immunotherapy of autoimmune diseases 139
Extra-articular manifestations of rheumatoid arthritis: an update 136
Human CD4 internal antigen anti-idiotypic monoclonal antibody. Immunochemical and sequence analysis 135
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 134
Case series on amyloidosis and organ involvement: a single center experience 134
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 134
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 132
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 132
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 130
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 125
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 122
Adult-onset Still's disease with elderly onset: results from a multicentre study 121
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 121
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 121
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 120
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 119
Endothelial cells in tumor microenvironment: insights and perspectives 117
Anticorpi monoclonali nell'immunoterapia delle malattie autoimmuni 117
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 115
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 114
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 109
Echocardiographic alteration in patients with systemic lupus erythematosus affected by hepatic steatosis: a cross-sectional single center study 108
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 106
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma 106
HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling ASAS criteria: Comparison with psoriatic and undifferentiated spondyloarthritis 105
B2 microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin’s and non Hodgkin’s lymphomas 105
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 104
Beta2-m-free heavy chain levels of HLA-class I antigen combined with serum IgM or platelet count provide two reliable staging systems in multiple myeloma 103
Analisi molecolare di un anticorpo monoclonale (AcMo) anti-idiotipo “immagine interna” dell’antigene CD4 101
An 82-year-old woman with new onset of multiple purple-reddish nodules during treatment with abatacept for rheumatoid arthritis 100
Efficacy, Safety, and Predictor of Response to Belimumab in a Large Nationwide Cohort Study of Patients with Active Systemic Lupus Erythematosus. 100
An atypical presentation of intestinal neuroendocrine tumor. 100
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 99
Vasculiti primarie sistemiche 98
Amicrobial pustulosis or erosive pustular dermatosis of the inguinal folds: broad of the same spectrum? 98
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 97
Raynaud’s phenomenon: from molecular pathogenesis to therapy 95
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 94
Involvement of FAB subclass-specific determinants in the interaction of human IgG with Streptococcal Protein (PG) 93
Membrane-type metalloprotease activity and HLA class I mRNA splicing in generating tFHC variants in multiple myeloma: clinical significance 92
Constrictive pericarditis due to AL amyloidosis: a case report. 91
B2 microglobulin (b2m)-free HLA class I heavy chain as prognostic marker of multiple myeloma 90
Beta-2 microglobulin-free HLA-A class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally toserum FHC expression 89
Monoclonal antibodies (mAb) in the immunotherapy (IT) of autoimmune disease (AD) 87
The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma 87
Ruolo degli autoanticorpi nelle patologie autoimmuni 87
Clinical use of erythropoietin 87
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 87
La neutropenia nei pazienti in trattamento: differenziazione dei fattori di crescita 86
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 82
Ruolo degli autoanticorpi nelle patologie autoimmuni 82
Minimum structural requirement for CD4 mimicry by anti-idiotipic mAb 16D7 81
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 81
P87 MEDIASTINAL SYNDROME REVEALED HEART LOCALIZATION OF A PRIMARY MEDIASTINAL B-CELL LYMPHOMA 79
Beta 2-microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin's and non-Hodgkin's lymphomas 79
Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis 78
Immunoparesisi in multiple myeloma 77
null 77
Vasculiti primarie sistemiche 77
BETA-2 microglobulin (beta2m)-free HLA Class I heavy chain as prognostic marker of multiple myeloma 76
Paradoxical embolism: relationship between foramen ovale pervious and renal infarction. 76
Systemic lupus erythematosus therapy: new possibilities since 50 years 75
Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review) 75
Dosaggio della catena pesante degli antigeni di Istocompatibilita' in pazienti con mieloma multiplo (MM) 74
Two structurally different peptides mimic a CD20 epitope recognized by rituximab 74
Functional characterization of peptides mimicking the CD20 epitope recognized by Rituximab 73
Savage therapy with rituximab in severe lupus nephritis. 73
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 73
Galectin-3 and Neutrophil-to-Lymphocyte ratio are indicative of heart remodelling and disease severity in patients with Obstructive Sleep Apnoea 72
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 70
Totale 12.454
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.300
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022690 0 0 6 34 28 65 60 45 38 43 143 228
2022/20231.530 193 201 114 140 164 216 33 180 217 11 42 19
2023/2024701 49 107 37 65 51 179 12 48 23 29 25 76
2024/20252.429 90 26 192 71 62 195 265 241 83 151 359 694
2025/20265.582 781 253 347 634 622 304 625 202 572 480 183 579
2026/2027684 213 271 200 0 0 0 0 0 0 0 0 0
Totale 15.380